Myeloid-derived suppressor activity is mediated by monocytic lineages maintained by continuous inhibition of extrinsic and intrinsic death pathways

Immunity

Volumn 41, Issue 6, 2014, Pages 947-959

  Haverkamp, Jessica M ^a   Smith, Amber M ^a   Weinlich, Ricardo ^a   Dillon, Christopher P ^a   Qualls, Joseph E ^a,f   Neale, Geoffrey ^a   Koss, Brian ^a   Kim, Young ^b   Bronte, Vincenzo ^c   Herold, Marco J ^d,e   Green, Douglas R ^a   Opferman, Joseph T ^a   Murray, Peter J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2-RELATED PROTEIN A1; CASPASE 8; CFLAR PROTEIN, MOUSE; FADD PROTEIN, MOUSE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; MCL1 PROTEIN, MOUSE; PROTEIN BCL 2; PROTEIN MCL 1; SMALL INTERFERING RNA;

ANIMAL; APOPTOSIS; BONE MARROW CELL; C57BL MOUSE; CANCER TRANSPLANTATION; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; COCULTURE; EXPERIMENTAL NEOPLASM; GENETICS; GRANULOCYTE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MONOCYTE; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARCINOGENESIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL LINEAGE; COCULTURE TECHNIQUES; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GRANULOCYTES; IMMUNE TOLERANCE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; MYELOID CELLS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84918555897     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.10.020     Document Type: Article

References (51)

1. Condamine T., Kumar V., Ramachandran I.R., Youn J.I., Celis E., Finnberg N., El-Deiry W.S., Winograd R., Vonderheide R.H., English N.R., et al. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. J.Clin. Invest. 2014, 124:2626-2639.
2. Dillon C.P., Oberst A., Weinlich R., Janke L.J., Kang T.B., Ben-Moshe T., Mak T.W., Wallach D., Green D.R. Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep 2012, 1:401-407.
3. Dolcetti L., Peranzoni E., Bronte V. Measurement of myeloid cell immune suppressive activity. Curr Protoc Immunol 2010, Chapter 14. Unit 14 17.
4. Dzhagalov I., St John A., He Y.W. The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. Blood 2007, 109:1620-1626.
5. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009, 9:162-174.
6. Gabrilovich D.I., Bronte V., Chen S.H., Colombo M.P., Ochoa A., Ostrand-Rosenberg S., Schreiber H. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 2007, 67:425.
7. Gabrilovich D.I., Ostrand-Rosenberg S., Bronte V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 2012, 12:253-268.
8. Gajewski T.F., Schreiber H., Fu Y.X. Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 2013, 14:1014-1022.
9. Galon J., Angell H.K., Bedognetti D., Marincola F.M. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity 2013, 39:11-26.
10. Germano G., Frapolli R., Belgiovine C., Anselmo A., Pesce S., Liguori M., Erba E., Uboldi S., Zucchetti M., Pasqualini F., et al. Role of macrophage targeting in the antitumor activity of trabectedin. Cancer Cell 2013, 23:249-262.
11. Ginhoux F., Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 2014, 14:392-404.
12. Gordy C., Pua H., Sempowski G.D., He Y.W. Regulation of steady-state neutrophil homeostasis by macrophages. Blood 2011, 117:618-629.
13. Green D.R., Oberst A., Dillon C.P., Weinlich R., Salvesen G.S. RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts. Mol. Cell 2011, 44:9-16.
14. Haverkamp J.M., Crist S.A., Elzey B.D., Cimen C., Ratliff T.L. Invivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site. Eur. J. Immunol. 2011, 41:749-759.
15. Highfill S.L., Rodriguez P.C., Zhou Q., Goetz C.A., Koehn B.H., Veenstra R., Taylor P.A., Panoskaltsis-Mortari A., Serody J.S., Munn D.H., et al. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 2010, 116:5738-5747.
16. Hu X., Li B., Li X., Zhao X., Wan L., Lin G., Yu M., Wang J., Jiang X., Feng W., et al. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2. J.Immunol. 2014, 192:1320-1331.
17. Huang Q.Q., Perlman H., Huang Z., Birkett R., Kan L., Agrawal H., Misharin A., Gurbuxani S., Crispino J.D., Pope R.M. FLIP: a novel regulator of macrophage differentiation and granulocyte homeostasis. Blood 2010, 116:4968-4977.
18. Kowanetz M., Wu X., Lee J., Tan M., Hagenbeek T., Qu X., Yu L., Ross J., Korsisaari N., Cao T., et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc. Natl. Acad. Sci. USA 2010, 107:21248-21255.
19. Lee H.H., Dadgostar H., Cheng Q., Shu J., Cheng G. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA 1999, 96:9136-9141.
20. Manz M.G., Boettcher S. Emergency granulopoiesis. Nat. Rev. Immunol. 2014, 14:302-314.
21. Marigo I., Bosio E., Solito S., Mesa C., Fernandez A., Dolcetti L., Ugel S., Sonda N., Bicciato S., Falisi E., et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010, 32:790-802.
22. McAllister S.S., Weinberg R.A. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat. Cell Biol. 2014, 16:717-727.
23. Motz G.T., Coukos G. Deciphering and reversing tumor immune suppression. Immunity 2013, 39:61-73.
24. Movahedi K., Guilliams M., Van den Bossche J., Van den Bergh R., Gysemans C., Beschin A., De Baetselier P., Van Ginderachter J.A. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct Tcell-suppressive activity. Blood 2008, 111:4233-4244.
25. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140:871-882.
26. Newton K., Dugger D.L., Wickliffe K.E., Kapoor N., de Almagro M.C., Vucic D., Komuves L., Ferrando R.E., French D.M., Webster J., et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 2014, 343:1357-1360.
27. Opferman J.T., Letai A., Beard C., Sorcinelli M.D., Ong C.C., Korsmeyer S.J. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003, 426:671-676.
28. Opferman J.T., Iwasaki H., Ong C.C., Suh H., Mizuno S., Akashi K., Korsmeyer S.J. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005, 307:1101-1104.
29. Ottina E., Grespi F., Tischner D., Soratroi C., Geley S., Ploner A., Reichardt H.M., Villunger A., Herold M.J. Targeting antiapoptotic A1/Bfl-1 by invivo RNAi reveals multiple roles in leukocyte development in mice. Blood 2012, 119:6032-6042.
30. Peranzoni E., Zilio S., Marigo I., Dolcetti L., Zanovello P., Mandruzzato S., Bronte V. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 2010, 22:238-244.
31. Perlman H., Pagliari L.J., Georganas C., Mano T., Walsh K., Pope R.M. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J.Exp. Med. 1999, 190:1679-1688.
32. Priceman S.J., Sung J.L., Shaposhnik Z., Burton J.B., Torres-Collado A.X., Moughon D.L., Johnson M., Lusis A.J., Cohen D.A., Iruela-Arispe M.L., Wu L. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy. Blood 2010, 115:1461-1471.
33. Restifo N.P., Dudley M.E., Rosenberg S.A. Adoptive immunotherapy for cancer: harnessing the Tcell response. Nat. Rev. Immunol. 2012, 12:269-281.
34. Ryan S.O., Johnson J.L., Cobb B.A. Neutrophils confer Tcell resistance to myeloid-derived suppressor cell-mediated suppression to promote chronic inflammation. J.Immunol. 2013, 190:5037-5047.
35. Sade-Feldman M., Kanterman J., Ish-Shalom E., Elnekave M., Horwitz E., Baniyash M. Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 2013, 38:541-554.
36. Schouppe E., Mommer C., Movahedi K., Laoui D., Morias Y., Gysemans C., Luyckx A., De Baetselier P., Van Ginderachter J.A. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events. Eur. J. Immunol. 2013, 43:2930-2942.
37. Srivastava M.K., Zhu L., Harris-White M., Kar U.K., Huang M., Johnson M.F., Lee J.M., Elashoff D., Strieter R., Dubinett S., Sharma S. Myeloid suppressor cell depletion augments antitumor activity in lung cancer. PLoS ONE 2012, 7:e40677.
38. Steimer D.A., Boyd K., Takeuchi O., Fisher J.K., Zambetti G.P., Opferman J.T. Selective roles for antiapoptotic MCL-1 during granulocyte development and macrophage effector function. Blood 2009, 113:2805-2815.
39. Talmadge J.E., Gabrilovich D.I. History of myeloid-derived suppressor cells. Nat. Rev. Cancer 2013, 13:739-752.
40. Teitz T., Stanke J.J., Federico S., Bradley C.L., Brennan R., Zhang J., Johnson M.D., Sedlacik J., Inoue M., Zhang Z.M., et al. Preclinical models for neuroblastoma: establishing a baseline for treatment. PLoS ONE 2011, 6:e19133.
41. Ugel S., Peranzoni E., Desantis G., Chioda M., Walter S., Weinschenk T., Ochando J.C., Cabrelle A., Mandruzzato S., Bronte V. Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. Cell Rep 2012, 2:628-639.
42. Vasquez-Dunddel D., Pan F., Zeng Q., Gorbounov M., Albesiano E., Fu J., Blosser R.L., Tam A.J., Bruno T., Zhang H., et al. STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients. J.Clin. Invest. 2013, 123:1580-1589.
43. Wang C.Y., Guttridge D.C., Mayo M.W., Baldwin A.S. NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell. Biol. 1999, 19:5923-5929.
44. Wang X., Bathina M., Lynch J., Koss B., Calabrese C., Frase S., Schuetz J.D., Rehg J.E., Opferman J.T. Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction. Genes Dev. 2013, 27:1351-1364.
45. Weber A., Boger R., Vick B., Urbanik T., Haybaeck J., Zoller S., Teufel A., Krammer P.H., Opferman J.T., Galle P.R., et al. Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice. Hepatology 2010, 51:1226-1236.
46. Weinlich R., Oberst A., Dillon C.P., Janke L.J., Milasta S., Lukens J.R., Rodriguez D.A., Gurung P., Savage C., Kanneganti T.D., Green D.R. Protective roles for caspase-8 and cFLIP in adult homeostasis. Cell Rep 2013, 5:340-348.
47. Weiss W.A., Aldape K., Mohapatra G., Feuerstein B.G., Bishop J.M. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 1997, 16:2985-2995.
48. Wu W.C., Sun H.W., Chen H.T., Liang J., Yu X.J., Wu C., Wang Z., Zheng L. Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients. Proc. Natl. Acad. Sci. USA 2014, 111:4221-4226.
49. Yin B., Ma G., Yen C.Y., Zhou Z., Wang G.X., Divino C.M., Casares S., Chen S.H., Yang W.C., Pan P.Y. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J.Immunol. 2010, 185:5828-5834.
50. Youn J.I., Collazo M., Shalova I.N., Biswas S.K., Gabrilovich D.I. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J.Leukoc. Biol. 2012, 91:167-181.
51. Zhao X., Rong L., Zhao X., Li X., Liu X., Deng J., Wu H., Xu X., Erben U., Wu P., et al. TNF signaling drives myeloid-derived suppressor cell accumulation. J.Clin. Invest. 2012, 122:4094-4104.